C00-C97
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients within follow-up after malignant cancer (all entities); completion of medical system therapy (chemotherapy) at least 6 months ago; patients with existing CIPN (anamnesis); age = = 18 years.
Exclusion criteria
Exclusion criteria: Palliative patients or patients with advanced cancer; patients undergoing acute cancer therapy; polyneuropathy of other etiologies (diabetes mellitus, alcohol abuse, etc.); medications that cause polyneuropathy; participation in another study involving exercise intervention; medical conditions that compromise patient safety or study feasibility.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of CIPN (EORTC-QLQ-CIPN20) baseline (week 0) versus post assessment (week 12) | — |
Secondary
| Measure | Time frame |
|---|---|
| CIPN (Common Terminology Criteria for Adverse Events (CTCAE), Peripheral deep sensitivity (Tuning fork), Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), Numeric Rating Scale), coordinative performance (Single Leg Stance, Short Physical Performance Battery, SPPB), physical activity (Bewegungs- und Sportaktivität Fragebogen, BSA-Fragebogen), quality of life (EORTC-QLQ-C30), feasibility | — |
Countries
Germany
Contacts
Universitätsklinikum Hamburg-Eppendorf